Pagaya Technologies Ltd
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the consolidated financial statements
NOTE 1 -BUSINESS DESCRIPTION
Pagaya Technologies Ltd. and its consolidated subsidiaries (together “we” “our” “Pagaya” or the “Company”) is a technology company that deploys sophisticated data science and proprietary AI technology to drive better results for financial services and other service providers, their customers, and asset investors. Services providers integrated with Pagaya’s network, which are referred to as “Partners,” range from high-growth financial technology companies to incumbent banks and financial institutions, auto finance providers and residential real estate service providers. Partners have access to Pagaya’s network in order to assist with extending financial products to their customers, in turn helping those customers fulfill their financial needs and dreams. These assets originated by Partners with the assistance of Pagaya’s AI technology are eligible to be acquired by (i) funds managed or advised by Pagaya or one of its affiliates, (ii) securitization vehicles sponsored or administered by Pagaya or one of its affiliates and (iii) other similar vehicles (“Financing Vehicles”).
Pagaya Technologies Ltd. was founded in 2016 and is organized under the laws of the State of Israel. Pagaya has its primary offices in the United States and Israel.
Reverse Share Split
Share amounts have been retrospectively adjusted to reflect the 1-for-12 reverse share split effected on March 8, 2024.
NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the accounts of the Company, its wholly-owned subsidiaries, and consolidated variable interest entities (“VIEs”) if any.
The accompanying unaudited condensed consolidated financial statements were derived from the audited consolidated financial statements, but does not include all of the disclosures, including certain notes required by GAAP on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K.
All intercompany accounts and transactions have been eliminated. The Company’s functional and reporting currency is the U.S. Dollar. In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements, except as noted below, and reflect all adjustments, which include only normal recurring adjustments necessary for the fair presentation of the Company’s financial position as of September 30, 2024 and the Company’s consolidated results of operations and shareholders’ equity for the three and nine months ended September 30, 2024 and 2023, and cash flows for the nine months ended September 30, 2024 and 2023. The results for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the full year ending December 31, 2024 or any other future interim or annual period.
Significant Accounting Policies
There were no material changes to our significant accounting policies as disclosed in Note 2, Summary of Significant Accounting Policies, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on April 25, 2024.
Recent Accounting Pronouncements Not Yet Adopted
As an “emerging growth company,” the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. Specifically, the new guidance requires disclosure, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker, and an amount for other segment items by reportable segment, with a description of its composition. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, and provide new segment disclosure requirements for entities with a single reportable segment. This ASU is effective for the Company beginning in fiscal year 2024 and interim periods within fiscal year 2025, with early adoption permitted. The Company is currently evaluating the impact of the amendments to its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update require entities to disclose specific categories in the effective tax rate reconciliation and provide additional information for reconciling items where the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income/loss by the applicable statutory income tax rate. In addition, entities are required to disclose the year-to-date amount of income taxes paid (net of refunds received) disaggregated by jurisdictions. This ASU is effective for the Company for annual periods beginning after December 15, 2025, with early adoption permitted. The Company is currently evaluating the impact of these amendments on its consolidated financial statements and related disclosures.
Recent Accounting Pronouncements Adopted
In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity,” which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. The guidance became effective for the Company beginning January 1, 2024. The adoption of the guidance did not have a material impact on the Company’s financial statements.
NOTE 3 -REVENUE
Revenue From Fees
Revenue from fees is comprised of Network AI fees and Contract fees. Network AI fees can be further broken down intotwo fee streams: AI integration fees and capital markets execution fees. AI integration fees are earned for the creation and delivery of assets that comprise Network Volume. The Company utilizes multiple funding channels to enable the purchase of network assets from Partners, such as asset backed securitizations (“ABS”). Capital markets execution fees are earned from the market pricing of ABS transactions while contract fees are management, performance and similar fees. These fees are the result of agreements with customers and are recognized in accordance with FASB Accounting Standards Codification 606, “Revenue from Contracts with Customers” (“ASC 606”).
Revenue is generally recognized on a gross basis in accordance with ASC 606 related to reporting revenue on a gross basis as a principal versus on a net basis as an agent. This is because the Company is primarily responsible for integrating the various services fulfilled by Partners and is ultimately responsible to the Financing Vehicles for the fulfillment of the related services. To the extent the Company does not meet the criteria for recognizing revenue on a gross basis, the Company records revenue on a net basis.
Network AI fees, comprised of AI integration fees and capital markets execution fees, totaled $229.1 million and $184.0 million for the three months ended September 30, 2024 and 2023, respectively, and $666.2 million and $505.5 million for the nine months ended September 30, 2024 and 2023, respectively. The Company recognizes Network AI fees primarily at a point in time when the related performance obligation is satisfied. From time to time the Company may provide certain incentives to Financing Vehicles. When the Company determines that an incentive is consideration payable, which is not in exchange for distinct goods or services, to a customer, the incentive is recorded as a reduction of revenue. Expenses to third parties for services that are integrated with the Company’s technology are recorded in the consolidated statements of operations as Production Costs.
Real estate fees, which are included in Network AI fees, are earned for the obligations to arrange for the purchase of real estate assets, provide administrative services, arrange for the eventual sale of the assets, and provide pre-and post-purchase services including the right to earn performance fees. All of these fees are recognized over time except for the purchase and sale obligations, which are satisfied at the point in time of the respective transactions. As the Company is a principal for these services, revenues are recorded on a gross basis.
Contract fees include administration and management fees, performances fees, and servicing fees. Contract fees totaled $20.1 million and $17.4 million for the three months ended September 30, 2024 and 2023, respectively, and $62.7 million and $56.9 million for the nine months ended September 30, 2024 and 2023, respectively. The Company recognizes administration fees over the service period for the Financing Vehicles managed or administered by the Company.
Performance fees are earned when certain Financing Vehicles exceed contractual return thresholds. They are recognized only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. An estimate is made by the Company based on a variety of factors including market conditions and expected loan performance. In the following period, the true performance is measured and then adjusted to ensure that the fees accurately represent actual performance. As such, there are revenues that result from performance obligations satisfied in the previous year. During the three months ended September 30, 2024, $0.3 million worth of fees represent performance obligations satisfied in 2023 that were less than the original estimate. During the nine months ended September 30, 2024, $2.9 million worth of fees represent performance obligations satisfied in 2023 that were greater than the original estimate. During the three and nine months ended September 30, 2023, $1.8 million and $0.1 million, respectively, worth of fees represent performance obligations satisfied in 2022 that were greater than the original estimate.
Servicing fees for the Financing Vehicles, which primarily involve collecting payments and providing reporting on the loans within the securitization vehicles, are recognized over the service period. These duties have been considered to be agent responsibilities and does not include acting as a loan servicer. Accordingly, servicing fees are recorded on a net basis.
The Company determines its contracts generally to not include a significant financing component since the Company's selling prices are not subjected to billing terms nor is its purpose to receive financing from its customers or to provide customers with financing. In addition, as a practical expedient, the Company does not adjust the transaction price for the effects of a significant financing component if, at contract inception, the period between payment and the transfer of services is expected to be one year or less.
Once revenue is recognized, it is recorded on the balance sheet in fees and other receivables until the payment is received from the customer. The timing of the recognition depends on the type of service as described above.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (in thousands) | ||||
| Services transferred at a point in time | $235,594 | $191,379 | $691,485 | $535,684 |
| Services transferred over time | 13,689 | 10,068 | 37,396 | 26,702 |
| Total revenue from fees, net | $249,283 | $201,447 | $728,881 | $562,386 |
The Company had no material contract assets, contract liabilities, or deferred contract costs recorded as of September 30, 2024 or December 31, 2023.
Concentrations of Credit Risk and Significant Customers
Financial instruments, which potentially subject the Company to concentration of credit risk, consist primarily of cash and cash equivalents, restricted cash and fees receivable. Cash and cash equivalents are principally maintained with major financial institutions, which management assesses to be of high credit quality. The Company has not experienced any losses on these deposits.
The Company’s fees receivable balances are predominantly with agreements with customers, and these are subject to normal credit risks which management believes to be not significant.
Significant customers are those which represent 10% or more of the Company’s total revenue for each respective period presented. Four customers, including three related parties, individually represented greater than 10% of total revenue and collectively totaled approximately 65% for three months ended September 30, 2024. Two customers, including one related party, individually represented greater than 10% of total revenue and collectively totaled approximately 25% for nine months ended September 30, 2024. Four customers, including three related parties, individually represented greater than 10% of total revenue and collectively totaled approximately 71% for the three months ended September 30, 2023. Two related party customers individually represented greater than 10% of total revenue and collectively totaled approximately 24% for the nine months ended September 30, 2023.
NOTE 4 -BORROWINGS
As of September 30, 2024 and December 31, 2023, the Company had secured borrowings, inclusive of current and non-current portions, with an outstanding balance of $408.7 million and $271.7 million, respectively, long-term debt, inclusive of current and non-current portions, with an outstanding balance of $230.2 million and $0.0 million, respectively, and a revolving credit facility with an outstanding balance of $15.0 million and $90.0 million, respectively. The Company was in compliance with all covenants as of September 30, 2024.
Risk Retention Master Repurchase
In normal course of business, the Company, through consolidated VIEs, enters into repurchase agreements to finance the Company’s risk retention balance in notes and certificates retained from securitization transactions. Under these agreements, the Company pledges financial instruments as collateral. These agreements with counterparties generally contain contractual provisions allowing the counterparty the right to sell or repledge the collateral. Pledged securities owned that can be sold or repledge by the counterparty are included in Investments in loans and securities in the Company’s balance sheet. As of September 30, 2024 and December 31, 2023, the outstanding principal balance under the repurchase agreements was $378.3 million and $251.4 million, respectively, which is recorded within secured borrowing on the consolidated balance sheet, with a weighted average interest rate of approximately sixteen percent andthirteen percent, respectively. The average remaining contractual maturities of the repurchase agreements were greater than 90 days as of both September 30, 2024 and December 31, 2023.
Receivables Facility
In October 2022, Pagaya Receivables LLC, a wholly-owned subsidiary, entered into a Loan and Security Agreement (the “LSA Agreement”) with certain lenders, which provides for a 3-year loan facility (the “Receivables Facility”) in a maximum principal amount of $22 million to finance certain eligible receivables purchased from sponsored securitization transactions. In June 2023, the Company amended the agreement and increased the maximum principal amount by $10 million to $32 million. In June 2024, the Company amended the agreement pursuant to which the maximum principal amount was increased from $32 million to $45 million and the term was extended until June 2026. Borrowings under the Receivables Facility bear interest at a rate per annum equal to the adjusted term Secured Overnight Financing Rate (subject to a 0.00% floor) plus a margin of 3.50%, and the balance is repaid using cash proceeds received from the receivables. As of September 30, 2024 and December 31, 2023, the outstanding principal balance under the Receivables Facility was $30.4 million and $20.3 million, respectively, which is recorded within secured borrowing on the consolidated balance sheet.
Credit Agreement
On February 2, 2024, the Company entered into a certain Credit Agreement (the “Credit Agreement”) which provides for a 5-year senior secured revolving credit facility (the “Revolving Credit Facility”) in an initial principal amount of $25 million, which subsequently increased to $35 million, and a 5 year senior secured term loan facility (the “Term Loan Facility,” and together with the Revolving Credit Facility, the “Facilities”) in an initial principal amount of $255 million.
The Facilities replace the SVB Revolving Credit Facility. In addition to replacing the SVB Revolving Credit Facility, proceeds of borrowings under the Facilities may be used for general corporate purposes of the Company and its subsidiaries.
No amortization payments are required to be made in respect of borrowings under the Revolving Credit Facility. Amortization payments are required to be made in respect of the term loans under the Term Loan Facility in amount of 1.25% per quarter of the original principal amount of the term loans under the Term Loan Facility.
Borrowings under the Facilities bear interest at a rate per annum equal to, at the Company’s option, (i) a base rate (determined based on the prime rate and subject to a 2.00% floor) plus a margin of 6.50% or (ii) an adjusted term Secured Overnight Financing Rate (subject to a 1.00% floor) plus a margin of 7.50%. A commitment fee accrues on any unused portion of the commitments under the Revolving Credit Facility at a rate per annum of 0.25% and is payable quarterly in arrears. Accrued interest of $7.7 million was recorded within accrued expenses and other liabilities on the unaudited condensed consolidated balance sheet as of September 30, 2024.
As of September 30, 2024, the Company had an outstanding balance of $230.2 million, which is recorded within long-term debt on the unaudited condensed consolidated balance sheet, and its aggregate future maturities consists of the following (in thousands):
| September 30, 2024 | |
|---|---|
| 2024 | $3,188 |
| 2025 | 12,750 |
| 2026 | 12,750 |
| 2027 | 12,750 |
| 2028 | 12,750 |
| Thereafter | 191,250 |
| Total | 245,438 |
| Debt issuance costs | (15,264) |
| Total long-term debt, net of debt issuance costs | $230,174 |
As of September 30, 2024, the Company had letters of credit issued in the amount of $15.2 million, and $4.8 million of remaining capacity available under the Revolving Credit Facility.
As of December 31, 2023, the Company had an outstanding balance of $90.0 million under the SVB Revolving Credit Facility.
NOTE 5 -INVESTMENTS IN LOANS AND SECURITIES
The amortized cost, gross unrealized gains and losses, allowance for credit losses, and fair value of investments in loans and securities as of September 30, 2024 and December 31, 2023 were as follows (in thousands). As provided in Note 6, a portion of these investments in loans and securities are consolidated as a result of the Company’s determination that it is the primary beneficiary of certain VIEs.
| As of September 30, 2024 | |||||
|---|---|---|---|---|---|
| Investments in loans and securities, available for sale(1): | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value |
| Securitization notes | $278,376 | $514 | $(675) | $— | $278,215 |
| Securitization certificates | 971,470 | 13,314 | (93,548) | (251,125) | 640,111 |
| Other loans and receivables | 6,865 | — | — | (1,809) | 5,056 |
| Total | $1,256,711 | $13,828 | $(94,223) | $(252,934) | $923,382 |
(1) Excludes accrued interest receivable of $13.4 million included in Fees and other receivables.
| As of December 31, 2023 | |||||
|---|---|---|---|---|---|
| Investments in loans and securities, available for sale(1): | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value |
| Securitization notes | $91,654 | $629 | $(1,858) | $— | $90,425 |
| Securitization certificates | 715,646 | 18,684 | (11,578) | (98,679) | 624,073 |
| Other loans and receivables | 4,574 | — | — | (2,279) | 2,295 |
| Total | $811,874 | $19,313 | $(13,436) | $(100,958) | $716,793 |
(1) Excludes accrued interest receivable of $12.5 million included in Fees and other receivables.
The following tables set forth the fair value and gross unrealized losses on investments in loans and securities without an allowance for credit losses aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position, as of the dates indicated (in thousands):
| As of September 30, 2024 | ||||||
|---|---|---|---|---|---|---|
| Less than or equal to 1 year | Greater than 1 year | Total | ||||
| Investments in loans and securities, available for sale: | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses |
| Securitization notes | $68 | $(1) | $28,418 | $(674) | $28,486 | $(675) |
| Securitization certificates | 18,507 | (4,929) | — | — | 18,507 | (4,929) |
| Other loans and receivables | — | — | — | — | — | — |
| Total | $18,575 | $(4,930) | $28,418 | $(674) | $46,993 | $(5,604) |
| As of December 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| Less than or equal to 1 year | Greater than 1 year | Total | ||||
| Investments in loans and securities, available for sale: | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses |
| Securitization notes | $59,925 | $(1,858) | $— | $— | $59,925 | $(1,858) |
| Securitization certificates | 15,799 | (1,988) | — | — | 15,799 | (1,988) |
| Other loans and receivables | — | — | — | — | — | — |
| Total | $75,724 | $(3,846) | $— | $— | $75,724 | $(3,846) |
The following table sets forth the amortized cost and fair value of investments in loans and securities by contractual maturities, as of the date indicated (in thousands):
| As of September 30, 2024 | ||||||
|---|---|---|---|---|---|---|
| Within 1 year | Greater than 1 year, less than or equal to 5 years | Total | ||||
| Investments in loans and securities, available for sale: | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value |
| Securitization notes | $10,549 | $10,489 | $267,827 | $267,726 | $278,376 | $278,215 |
| Securitization certificates | 762 | 762 | 970,708 | 639,349 | 971,470 | 640,111 |
| Other loans and receivables | — | — | 6,865 | 5,056 | 6,865 | 5,056 |
| Total (1) | $11,311 | $11,251 | $1,245,400 | $912,131 | $1,256,711 | $923,382 |
| As of December 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| Within 1 year | Greater than 1 year, less than or equal to 5 years | Total | ||||
| Investments in loans and securities, available for sale: | Amortized Cost | Fair Value | Amortized Cost | Fair Value | Amortized Cost | Fair Value |
| Securitization notes | $2,405 | $2,387 | $89,249 | $88,038 | $91,654 | $90,425 |
| Securitization certificates | 103 | 103 | 715,543 | 623,970 | 715,646 | 624,073 |
| Other loans and receivables | — | — | 4,574 | 2,295 | 4,574 | 2,295 |
| Total (1) | $2,508 | $2,490 | $809,366 | $714,303 | $811,874 | $716,793 |
(1) Based on expected maturity date cash flows.
The following table sets forth gross proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of securities, for the periods indicated (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Investments in loans and securities, available for sale: | ||||
| Proceeds from sales/maturities/prepayments | $23,083 | $42,741 | $89,905 | $134,101 |
| Write-offs charged against the allowance | $4,810 | $37,758 | $7,109 | $38,636 |
| Additions to allowance for credit losses | $(79,171) | $(37,314) | $(159,085) | $(115,640) |
The following tables set forth the activity in the allowance for credit losses for investments in loans and securities, as of the dates indicated (in thousands):
| Three Months Ended September 30, 2024 | ||||
|---|---|---|---|---|
| Securitization notes | Securitization certificates | Other Loans and Receivables | Total | |
| Balance, beginning of period | $— | $(174,077) | $(4,053) | $(178,130) |
| Additions to allowance for credit losses not previously recorded | — | (21,118) | — | (21,118) |
| Additions (reductions) on securities with previous allowance | — | (55,930) | (2,123) | (58,053) |
| Write-offs charged against the allowance | — | — | 4,810 | 4,810 |
| Recoveries of amounts previously written off | — | — | (443) | (443) |
| Balance, end of period | $— | $(251,125) | $(1,809) | $(252,934) |
| Nine Months Ended September 30, 2024 | ||||
|---|---|---|---|---|
| Securitization notes | Securitization certificates | Other Loans and Receivables | Total | |
| Balance, beginning of period | $— | $(98,679) | $(2,279) | $(100,958) |
| Additions to allowance for credit losses not previously recorded | — | (112,263) | — | (112,263) |
| Additions to allowance for credit losses arising from purchases | — | — | (3,246) | (3,246) |
| Additions (reductions) on securities with previous allowance | — | (40,183) | (3,393) | (43,576) |
| Write-offs charged against the allowance | — | — | 7,109 | 7,109 |
| Recoveries of amounts previously written off | — | — | — | — |
| Balance, end of period | $— | $(251,125) | $(1,809) | $(252,934) |
| Three Months Ended September 30, 2023 | ||||
|---|---|---|---|---|
| Securitization notes | Securitization certificates | Other Loans and Receivables | Total | |
| Balance, beginning of period | $— | $(74,288) | $(3,160) | $(77,448) |
| Additions to allowance for credit losses not previously recorded | — | (36,999) | (315) | (37,314) |
| Write-offs charged against the allowance | — | 36,821 | 937 | 37,758 |
| Balance, end of period | $— | $(74,466) | $(2,538) | $(77,004) |
| Nine Months Ended September 30, 2023 | ||||
|---|---|---|---|---|
| Securitization notes | Securitization certificates | Other Loans and Receivables | Total | |
| Balance, beginning of period | $— | $— | $— | $— |
| Additions to allowance for credit losses not previously recorded | — | (111,287) | (4,353) | (115,640) |
| Write-offs charged against the allowance | — | 36,821 | 1,815 | 38,636 |
| Balance, end of period | $— | $(74,466) | $(2,538) | $(77,004) |
Equity Method and Other Investments
The following investments, including those accounted for under the equity method, are included within Equity method and other investments in the consolidated balance sheets as of September 30, 2024 and December 31, 2023 (in thousands):
| Carrying Value | ||
|---|---|---|
| September 30, 2024 | December 31, 2023 | |
| Investments in Pagaya SmartResi F1 Fund, LP (1) | $16,381 | $17,357 |
| Other (2) | 9,397 | 9,026 |
| Total | $25,778 | $26,383 |
(1) The Company owns approximately 5.4% and is the general partner of Pagaya Smartresi F1 Fund LP.
(2) Represents the Company’s proprietary investments. Income from these investments is included in Investment income in the consolidated statements of operations.
NOTE 6 -CONSOLIDATION AND VARIABLE INTEREST ENTITIES
The Company has variable interests in securitization vehicles that it sponsors. The Company consolidates VIEs when it is deemed to be the primary beneficiary. In order to be primary beneficiary, the Company must have a controlling financial interest in the VIE. This is determined by evaluating if the Company has both (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and (2) the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant.
Consolidated VIEs
As of September 30, 2024 and December 31, 2023, the Company has determined that it is the primary beneficiary of Pagaya Structured Holdings LLC, Pagaya Structured Holdings II LLC, and Pagaya Structured Holding III LLC (“Risk Retention Entities”). As sponsor of securitization transactions, the Company is subject to risk retention requirements and established the Risk Retention Entities to meet these requirements.
Below is a summary of assets and liabilities from the Company’s involvement with consolidated VIEs (i.e., Risk Retention Entities) (in thousands):
| Assets | Liabilities | Net Assets | |
|---|---|---|---|
| As of September 30, 2024 | $99,959 | $— | $99,959 |
| As of December 31, 2023 | $132,660 | $— | $132,660 |
Unconsolidated VIEs
The Company determined that it is not the primary beneficiary of the trusts which hold the loans and issue securities associated with the securitization transactions the Company sponsors. The Company does not have the power to direct or control the activities which most significantly affect the performance of the trusts, which was determined to be servicing loans.
The Company’s maximum exposure to loss from its involvement with unconsolidated VIEs represents the estimated loss that would be incurred under severe, hypothetical circumstances, for which the Company believes the possibility is remote, such as where the value of securitization notes and senior and residual certificates the Company holds as part of the risk retention requirement declines to zero.
Below is a summary of the Company’s direct interest in (i.e., not held through Risk Retention Entities) variable interests in nonconsolidated VIEs (in thousands):
| Carrying Amount | Maximum Exposure to Loss | VIE Assets | |
|---|---|---|---|
| As of September 30, 2024 | $828,444 | $828,444 | $10,044,814 |
| As of December 31, 2023 | $591,030 | $591,030 | $8,363,402 |
From time to time, the Company may, but is not obligated to, purchase assets from the Financing Vehicles. Such repurchases occur at the Company’s discretion. During the three and nine months ended September 30, 2024, the Company purchased approximately $14.5 million and $34.0 million, respectively, of loan principal from the Financing Vehicles and included a loss of approximately $12.8 million and $31.2 million, respectively, in general and administrative expenses with respect to these loans. During the three and nine months ended September 30, 2023, the Company didnot purchase any loans from the Financing Vehicles.
NOTE 7 -LEASES
The Company leases facilities under operating leases with various expiration dates through 2032. The Company leases office space in New York, Israel and several other locations.
The security deposits for the leases are $3.3 million and $4.8 million as of September 30, 2024 and December 31, 2023, respectively, which have been recognized as restricted cash, non-current in the unaudited condensed consolidated balance sheets.
The Company’s operating lease expense consists of rent and variable lease payments. Variable lease payments such as common area maintenance were included in operating expenses. Rent expense for the Company’s short-term leases was immaterial for the periods presented. Operating lease expense was as follows (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Rent expense | $2,900 | $3,275 | $8,748 | $10,061 |
| Variable lease payments | $87 | $72 | $260 | $203 |
| Sublease income | $999 | $1,035 | $3,007 | $3,154 |
Supplemental information related to the Company’s operating leases was as follows ($ in thousands):
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Weighted-average remaining lease term (in years) | 6.4 | 7.4 |
| Weighted-average discount rate | 8.7% | 6.1% |
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Operating lease right-of-use assets recognized in exchange for new operating lease obligations (1) | $(19,961) | $— | $(20,179) | $290 |
(1) During the three and nine months ended September 30, 2024, $20.0 million and $20.2 million, respectively, of operating lease right-of-use assets and corresponding lease liability were derecognized as a result of early termination.
Maturities of the Company’s operating lease liabilities as of September 30, 2024 were as follows (in thousands):
| 2024 | $2,355 |
| 2025 | 7,355 |
| 2026 | 7,000 |
| 2027 | 5,883 |
| 2028 | 5,093 |
| Thereafter | 15,104 |
| Total | 42,790 |
| Less: imputed interest | (9,606) |
| Total operating lease liabilities | $33,184 |
NOTE 8 -COMMITMENTS AND CONTINGENCIES
Legal Proceedings— From time to time the Company is subject to legal proceedings and claims in the ordinary course of business. The results of such matters often cannot be predicted with certainty. In accordance with applicable accounting guidance, the Company establishes an accrued liability for legal proceeding and claims when those matters present loss contingencies which are both probable and reasonably estimable. All such liabilities arising from current legal matters, to the extent such matters existed, have been recorded in accrued expenses and other liabilities on the consolidated statements of financial position and these matters are immaterial.
Contractual Obligations and Commitments— During 2023, the Company entered into a purchase commitment with our third-party cloud computing web services provider, which included an annual purchase commitment of $4.6 million for the period from October 2023 through September 2025. As of September 30, 2024, the total remaining contractual obligations are approximately $4.9 million, all of which is for the next 12 months. The Company may pay more than the minimum purchase commitment based on usage.
Guarantees and Indemnifications— In the ordinary course of business, the Company may provide indemnifications or loss guarantees of varying scope and terms to customers and other third parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. These indemnifications may survive termination of the underlying agreement and the maximum potential amount of future indemnification payments may not be subject to a cap. As of September 30, 2024, there have been no known events or circumstances that have resulted in a material indemnification liability and the Company did not incur material costs to defend lawsuits or settle claims related to these indemnifications. For certain contracts meeting the definition of a guarantee or a derivative, the guarantor must recognize, at inception and each reporting period, a liability for the fair value of the obligation undertaken in issuing the guarantee. In addition, the guarantor must disclose the maximum potential amount of future payments that the guarantor could be required to make under the guarantee, if there were a default by the guaranteed parties. The determination of the maximum potential future payments is based on the notional amount of the guarantees without consideration of possible recoveries under recourse provisions or from collateral held or pledged. As of September 30, 2024, the maximum potential amount of undiscounted future payments the Company could be required to make under these guarantees totaled $30.1 million. In accordance with the guarantee contracts, the maximum potential payment amount has been segregated and recognized within restricted cash in the unaudited condensed consolidated balance sheet.
NOTE 9 -TRANSACTIONS WITH RELATED PARTIES
In the ordinary course of business, the Company may enter into transactions with directors, principal officers, their immediate families, and affiliated companies in which they are principal shareholders (commonly referred to as related parties). In addition, the Company has transactions with the securitization vehicles and other Financing Vehicles, which are also related parties.
As of September 30, 2024, the total fee receivables from related parties are $86.4 million, which consist of $78.9 million from securitization vehicles and $7.5 million from other Financing Vehicles. As of December 31, 2023, the total fee receivables from related parties are $84.8 million, which consists of $78.4 million from securitization vehicles and $6.3 million from other Financing Vehicles.
As of September 30, 2024 and December 31, 2023, prepaid expenses and other assets include amounts due from related parties of $15.7 million and $7.9 million, respectively, all of which were attributable to Financing Vehicles.
For the three months ended September 30, 2024, the total revenue from related parties is $174.2 million, which consists of $154.3 million from securitization vehicles and $19.9 million from other Financing Vehicles. For the nine months ended September 30, 2024, the total revenue from related parties is $528.0 million, which consists of $474.1 million from securitization vehicles and $53.9 million from other Financing Vehicles. For the three months ended September 30, 2023, the total revenue from related parties is $157.6 million, which consists of $149.0 million from securitization vehicles and $8.6 million from other Financing Vehicles. For the nine months ended September 30, 2023, the total revenue from related parties is $459.6 million, which consists of $418.4 million from securitization vehicles and $41.2 million from other Financing Vehicles.
From time to time, the Company may, but is not obligated to, purchase assets from the Financing Vehicles. Such repurchases occur at the Company’s discretion. During the three and nine months ended September 30, 2024, the Company purchased approximately $14.5 million and $34.0 million, respectively, of loan principal from the Financing Vehicles and included a loss of approximately $12.8 million and $31.2 million, respectively, in general and administrative expenses with respect to these loans. During the three and nine months ended September 30, 2023, the Company didnot purchase any loans from the Financing Vehicles.
NOTE 10 -FAIR VALUE MEASUREMENT
FASB ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles, and requires certain disclosures about fair value measurements. In general, fair values of financial instruments are based upon quoted market prices, when available. If such quoted market prices are not available, fair value is based upon models that use, as inputs, observable market-based parameters to the greatest extent possible.
Financial Assets and Liabilities Recorded at Fair Value
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands):
| September 30, 2024 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Assets: | ||||
| Investments in loans and securities (Notes) | $— | $48,530 | $229,685 | $278,215 |
| Investments in loans and securities (Certificates and Other loans and receivables) | — | — | 645,167 | 645,167 |
| Liabilities: | ||||
| Warrant liability | $1,874 | $1,010 | $— | $2,884 |
| December 31, 2023 | ||||
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |
| Assets: | ||||
| Investments in loans and securities (Notes) | $— | $90,425 | $— | $90,425 |
| Investments in loans and securities (Certificates and Other loans and receivables) | — | — | 626,368 | 626,368 |
| Liabilities: | ||||
| Warrant liability | $2,106 | $1,136 | $— | $3,242 |
Assets and Liabilities Measured at Fair Value on a Recurring Basis (Level 1 and 2)
Warrant liability (Level 1 and 2)
The Company used the value of the Public Warrants (Level 1) as an approximation of the value of the Private Warrants as they are substantially similar to the Public Warrants, but not directly traded or quoted on an active market.
The following tables summarize the Warrant liability activity for the three and nine months ended September 30, 2024 and 2023 (in thousands):
| Three Months Ended September 30, 2024 | |
|---|---|
| Balance as of June 30, 2024 | $1,671 |
| Change in fair value | 1,213 |
| Balance as of September 30, 2024 | $2,884 |
| Nine Months Ended September 30, 2024 | |
|---|---|
| Balance as of December 31, 2023 | $3,242 |
| Change in fair value | (358) |
| Balance as of September 30, 2024 | $2,884 |
| Three Months Ended September 30, 2023 | |
|---|---|
| Balance as of June 30, 2023 | $3,835 |
| Change in fair value | 1,328 |
| Balance as of September 30, 2023 | $5,163 |
| Nine Months Ended September 30, 2023 | |
|---|---|
| Balance as of December 31, 2022 | $1,400 |
| Change in fair value | 3,763 |
| Balance as of September 30, 2023 | $5,163 |
Assets and Liabilities Measured at Fair Value on a Recurring Basis (Level 3)
Investments in Loans and Securities Available for Sale (Level 3)
As of September 30, 2024, the Company held investments in loans and securities classified as available for sale. These assets are measured at fair value using a discounted cash flow model, and presented within investments in loans and securities on the unaudited condensed consolidated balance sheets. Changes in the fair value, other than declines in fair value due to credit, are reflected in other comprehensive income (loss) on the unaudited condensed consolidated statements of comprehensive income (loss). Declines in fair value due to credit are reflected in other income (expenses), net on the unaudited condensed consolidated statements of operations.
The following tables summarize the activity related to the fair value of the investments in loans and securities available for sale (Level 3 only) for the three and nine months ended September 30, 2024 and 2023 (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Balance, beginning of period | $853,418 | $481,818 | $626,368 | $— |
| Transfer to Level 3(1) | — | — | 10,469 | 339,041 |
| Additions | 130,271 | 162,903 | 536,966 | 432,127 |
| Cash received | (13,077) | (25,942) | (55,649) | (78,208) |
| In-kind distributions | — | (11,460) | — | (11,460) |
| Change in fair value | (19,711) | 3,984 | (87,342) | 8,131 |
| Credit-related impairment loss, net of recoveries | (76,049) | (37,316) | (155,960) | (115,644) |
| Balance, end of period | $874,852 | $573,987 | $874,852 | $573,987 |
(1) Transfer in 2023 represents a transfer from held-to-maturity to available for sale at fair value, effectuated on January 1, 2023.
The following tables summarize the activity related to the fair value of the investments in loans and securities available for sale for the three and nine months ended September 30, 2024 and 2023 (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Balance, beginning of period | $911,425 | $590,455 | $716,793 | $— |
| Transfer from held-to-maturity to available for sale at fair value | — | — | — | 480,437 |
| Additions | 130,268 | 162,903 | 538,727 | 436,242 |
| Cash received | (23,083) | (42,741) | (89,905) | (134,101) |
| In-kind distributions (non-cash) | — | (12,730) | — | (12,730) |
| Change in fair value | (19,179) | 5,083 | (86,273) | 11,450 |
| Credit-related impairment loss, net of recoveries | (76,049) | (37,316) | (155,960) | (115,644) |
| Balance, end of period | $923,382 | $665,654 | $923,382 | $665,654 |
Significant unobservable inputs used for our Level 3 fair value measurement of the loans and securities are the discount rate, loss rate, and prepayment rate. Significant increases or decreases in any of the inputs in isolation could result in a significantly lower or higher fair value measurement.
The following tables present quantitative information about the significant unobservable inputs used for our Level 3 fair value measurement of the loans and securities as of September 30, 2024 and December 31, 2023:
| Unobservable Input | Minimum | Maximum | Weighted Average |
|---|---|---|---|
| Discount rate | 5.0% | 15.0% | 15.0% |
| Loss rate | 5.8% | 32.7% | 16.9% |
| Prepayment rate | 0.0% | 20.0% | 10.4% |
| Unobservable Input | Minimum | Maximum | Weighted Average |
|---|---|---|---|
| Discount rate | 8.0% | 15.0% | 15.0% |
| Loss rate | 4.9% | 31.0% | 15.7% |
| Prepayment rate | 4.0% | 40.0% | 9.9% |
Financial Assets and Liabilities Not Recorded at Fair Value
The Company believes that the carrying amount of cash, cash equivalents and restricted cash, fees and other receivables, accounts payables and other current liabilities approximate their fair value due to the short-term maturities of these instruments.
The below tables contain information about assets that are not measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023 (in thousands):
| September 30, 2024 | |||||
|---|---|---|---|---|---|
| Fair Value | |||||
| CarryingValue | Level 1 | Level 2 | Level 3 | Total | |
| Assets | |||||
| Cash, cash equivalents and restricted cash | $181,047 | $181,047 | $— | $— | $181,047 |
| Fees and other receivables | 129,063 | — | 129,063 | — | 129,063 |
| Total assets | $310,110 | $181,047 | $129,063 | $— | $310,110 |
| December 31, 2023 | |||||
|---|---|---|---|---|---|
| Fair Value | |||||
| CarryingValue | Level 1 | Level 2 | Level 3 | Total | |
| Assets | |||||
| Cash, cash equivalents and restricted cash | $222,541 | $222,541 | $— | $— | $222,541 |
| Fees and other receivables | 113,707 | — | 113,707 | — | 113,707 |
| Total assets | $336,248 | $222,541 | $113,707 | $— | $336,248 |
NOTE 11 -ORDINARY SHARES AND ORDINARY SHARE WARRANTS
As of September 30, 2024,839,999,998 shares with no par value are authorized, of which,6,666,666 shares are designated as Preferred Shares,666,666,666 shares are designated as Class A Ordinary Shares, and 166,666,666 shares are designated as Class B Ordinary Shares. As of September 30, 2024, the Company had 5,000,000 Preferred Shares outstanding,60,160,631 Class A Ordinary Shares outstanding and 12,652,310 Class B Ordinary Shares outstanding.
The rights of the holders of each class of Ordinary Shares are identical, except with respect to voting. Each Class A Ordinary Share is entitled toone vote per share. Each Class B Ordinary Share is entitled to 10 votes per share. Class B Ordinary Shares may be converted at any time at the option of the stockholder and automatically convert upon sale or transfer to a Class A Ordinary Share.
Reverse Share Split
Upon the approvals granted at the special general meeting of shareholders held on February 15, 2024, the Board has determined to implement a reverse share split of all of the Company’s ordinary and preferred shares, without par value, at a ratio of 1-for-12 with effective date of March 8, 2024. All references made to share or per share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect the effects of the reverse share split.
As of September 30, 2024 and December 31, 2023, the Company had reserved ordinary shares for future issuance as follows:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Share options | 3,489,238 | 4,250,988 |
| Options to restricted shares | 19,970,330 | 20,046,080 |
| RSUs | 3,155,558 | 3,034,203 |
| Ordinary share warrants | 2,154,586 | 2,076,014 |
| Redeemable convertible preferred shares | 5,000,000 | 5,000,000 |
| Shares available for future grant of equity awards(1) | 9,186,943 | 5,231,186 |
| Shares reserved for issuance under the ESPP | 832,713 | — |
| Total shares of ordinary share reserved | 43,789,368 | 39,638,471 |
(1) Reflects the application of the automatic increase of shares reserved under the Company's 2022 Share Incentive Plan (the "2022 Plan") on January 1 of 2023 and 2024 pursuant to the terms of the 2022 Plan. For more information on the automatic increases see our Form 10-K.
Ordinary Share Warrants
The Company has accounted for the ordinary share warrants as equity-classified warrants as they met the requirements for equity classification under ASC 815, including whether the ordinary share warrants are indexed to the Company’s own ordinary shares. For warrants that do not meet all the criteria for equity classification, the warrants are recorded at their initial fair value on the date of issuance and remeasured each balance sheet date thereafter. Changes in the estimated fair value of the liability-classified warrants are recognized as a non-cash other income or expense in the accompanying unaudited condensed consolidated statements of operations.
As of September 30, 2024, there were 433,942 warrants expiring in March 2031 with an exercise price of $0.00006 per share,192,900 warrants expiring in June 2030 with an exercise price of $0.0006 per share,220,000 warrants expiring in March 2032 with an exercise price of $0.12 per share,78,578 warrants expiring in September 2034 with an exercise price of $0.01 per share, and 1,229,166 warrants expiring in June 2027 (consisting of the Public Warrants and Private Placement Warrants) with an exercise price of $138 per share to purchaseone Class A Ordinary Share.
Ordinary Shares Purchase Agreement
During the three months ended September 30, 2024,516,512 shares were issued under the Equity Financing Purchase Agreement for net proceeds of $6.7 million, and related fee of $0.2 million was expensed. During the nine months ended September 30, 2024,814,569 shares were issued under the Equity Financing Purchase Agreement for net proceeds of $11.9 million, and related fee of $0.4 million was expensed. On September 25, 2024, the Company terminated the Equity Financing Purchase Agreement.
Ordinary Share Offering
On March 13, 2024, the Company priced an offering of 7,500,000 of its Class A Ordinary Shares, no par value, pursuant to an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc. and Jefferies LLC as representatives of the several underwriters. The proceeds from the offer and sale of the securities are approximately $90.0 million, after deducting the underwriting discount and fees and offering expenses payable by the Company.
NOTE 12 -SHARE BASED COMPENSATION
Share Options—Granted share options expire at the earlier of termination of employment orten years from the date of grant. Share options generally vest over four years of the employment commencement date or with 25% vesting on thetwelve-month anniversary of the employment commencement date, and the remaining on a pro-rata basis each quarter over the next three years. Any options, which are forfeited or not exercised before expiration, become available for future grants.
The following table summarized the Company’s share option activity during the nine months ended September 30, 2024:
| Number of Options · Weighted Average Exercise Price · Weighted AverageRemaining ContractualTerm (Years) · AggregateIntrinsic Value (000’s) | |||||||
|---|---|---|---|---|---|---|---|
| Balance, December 31, 2023 | 4,250,988 | $7.2 | 7.2 | $43,940 | |||
| Granted | 4,450 | — | |||||
| Exercised | (508,941) | 6.1 | |||||
| Forfeited | (257,259) | 21.2 | |||||
| Balance, September 30, 2024 | 3,489,238 | $6.4 | 6.4 | $20,949 | |||
| Vested and exercisable, September 30, 2024 | 3,148,937 | $5.3 | 6.3 | $22,276 | |||
The aggregate intrinsic value of options exercised was approximately $3.2 million and $7.6 million for the nine months ended September 30, 2024 and 2023, respectively. The total fair value of share options vested for the nine months ended September 30, 2024 and 2023, was $58.8 million and $63.6 million, respectively.
The assumptions used to estimate the fair value of share options granted for the nine months ended September 30, 2024 September 30, 2024 were as follows:
| Expected volatility | 95.5% |
|---|---|
| Expected term (in years) | 5.7 |
| Risk free interest | 3.6% |
| Dividend yield | — |
As of September 30, 2024, unrecognized compensation expense related to unvested share options was approximately $21.4 million, which is expected to be recognized over a remaining weighted-average period of 0.8 years.
Restricted Stock Units (RSUs)—RSUs generally vest overtwo years of the employment commencement date with 50% vesting on thetwelve-month anniversary of the employment commencement date, and the remaining on a pro-rata basis each quarter over the remaining twelve months. RSUs granted are forfeited at termination of employment. Any RSUs, which are forfeited or not exercised before expiration, become available for future grants.
The following table summarized the Company’s RSU activity during the nine months ended September 30, 2024:
| Number of RSUs | Weighted Average Grant Date Fair Value Per Share | |
|---|---|---|
| Unvested at December 31,2023 | 3,034,203 | $15.6 |
| Granted | 2,803,283 | 10.9 |
| Vested | (1,872,182) | 13.8 |
| Forfeited | (809,746) | 15.2 |
| Unvested at September 30, 2024 | 3,155,558 | $12.6 |
As of September 30, 2024, unrecognized compensation expense related to RSUs was approximately $32.0 million, which is expected to be recognized over a remaining weighted-average period of 1.1 years.
Options to Restricted Shares—Options to restricted shares were granted to certain employees and directors during 2021. See Note 16 to the consolidated financial statements included in the Annual Report on Form 10-K for additional information.
The following table summarized the Company’s options to restricted shares activity during the nine months ended September 30, 2024:
| Number of Options | Weighted Average Exercise Price | Weighted AverageRemaining ContractualTerm (Years) | AggregateIntrinsic Value (000’s) | |
|---|---|---|---|---|
| Balance, December 31, 2023 | 20,046,080 | $19.4 | 7.2 | $— |
| Granted | — | — | ||
| Exercised | (14,858) | 12.2 | ||
| Forfeited | (60,892) | 40.6 | ||
| Balance, September 30, 2024 | 19,970,330 | $19.4 | 6.5 | $— |
| Vested and exercisable, September 30, 2024 | 16,541,299 | $19.3 | 6.5 | $— |
At September 30, 2024, unrecognized compensation expense related to options to restricted shares was approximately $13.1 million, which is expected to be recognized over a remaining weighted-average period of 1.4 years.
Employee Stock Purchase Plan—The Employee Stock Purchase Plan (“ESPP”) allows eligible employees to purchase shares of our Class A Ordinary Shares at a discounted price, normally through payroll deductions, subject to the terms of the ESPP and applicable law. During the three and nine months ended September 30, 2024,59,145 shares were issued under the ESPP. As of September 30, 2024,0.8 million shares of Class A Ordinary Shares were reserved for issuance under the ESPP. Compensation expense related to the ESPP was $0.4 million for the nine months ended September 30, 2024.
Share-Based Compensation Expense
The following table presents the components and classification of share-based compensation for the three and nine months ended September 30, 2024 and 2023 (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Technology, data and product development | $1,011 | $3,467 | $6,985 | $8,915 |
| Selling and marketing | 2,875 | 3,469 | 9,594 | 10,979 |
| General and administrative | 8,447 | 13,801 | 29,273 | 37,418 |
| Total | $12,333 | $20,737 | $45,852 | $57,312 |
NOTE 13 -INCOME TAXES
Corporate Income Tax - Ordinary taxable income in Israel is subject to a corporate tax rate of 23%.
Pagaya has received an approval from the Israeli Tax authorities for Preferred Technological Enterprise (“PTE”) status and received approval on November 18, 2021. The approval is effective for the tax years 2020 through 2024. Income from a PTE is subject to 12% tax rate.
Foreign Exchange Regulations in Israel
Under the Foreign Exchange Regulations, the Company calculates its tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into NIS according to the exchange rate as of December 31st of each year.
Non-Israeli subsidiaries are taxed according to the tax laws in their respective countries of residence.
The Company’s effective tax rates for the three and nine months ended September 30, 2024 and 2023 are as follows (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Loss before income taxes | $(85,755) | $(47,098) | $(180,581) | $(166,187) |
| Income tax expense (benefit) | (11,524) | (1,158) | 7,991 | 10,515 |
| Effective tax rate | 13.4% | 2.5% | (4.4)% | (6.3)% |
The Company’s tax rate is affected by recurring items, such as tax rates in foreign jurisdictions and the relative amounts of income the Company earns in those jurisdictions. The change in the effective tax rate was primarily due to discrete tax expenses related to a change in an uncertain tax position in the three and nine months ended September 30, 2024. The difference between the effective tax rate and the statuary tax rate in Israel mainly related to valuation allowance in Israel and tax expenses in the United States.
The Company regularly assesses the need for a valuation allowance against its deferred tax assets. In making that assessment, the Company considers both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized.
The Company provides a valuation allowance to offset certain deferred tax assets due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets.
NOTE 14 -NET LOSS PER SHARE
Net income (loss) per share is presented in conformity with the two-class method required for multiple classes of ordinary share and participating securities.
The following tables set forth the calculation of basic and diluted net loss per share attributable to ordinary shareholders for the three and nine months ended September 30, 2024 and 2023 (in thousands, except share and per share data):
| Three Months Ended September 30, 2024 | Nine Months Ended September 30, 2024 | |||
|---|---|---|---|---|
| Class A | Class B | Class A | Class B | |
| Numerator: | ||||
| Net loss attributable to Pagaya Technologies Ltd. ordinary shareholders, basic and diluted | $(55,737) | $(11,739) | $(133,773) | $(29,711) |
| Denominator: | ||||
| Weighted average shares used for net loss per ordinary share, basic and diluted | 60,076,357 | 12,652,310 | 56,967,503 | 12,652,310 |
| Net loss per share attributable to ordinary shareholders, basic and diluted | $(0.93) | $(0.93) | $(2.35) | $(2.35) |
| Three Months Ended September 30, 2023 | Nine Months Ended September 30, 2023 | |||
|---|---|---|---|---|
| Class A | Class B | Class A | Class B | |
| Numerator: | ||||
| Net loss attributable to Pagaya Technologies Ltd. ordinary shareholders, basic and diluted | $(16,672) | $(5,080) | $(86,396) | $(27,624) |
| Denominator: | ||||
| Weighted average shares used for net loss per ordinary share, basic and diluted | 46,533,452 | 14,180,196 | 45,173,807 | 14,443,853 |
| Net loss per share attributable to ordinary shareholders, basic and diluted | $(0.36) | $(0.36) | $(1.91) | $(1.91) |
The following potentially dilutive outstanding securities as of September 30, 2024 and 2023 were excluded from the computation of diluted net income (loss) per share because their effect would have been anti-dilutive for the periods:
| September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Share options | 3,161,986 | 4,486,788 |
| Options to restricted shares | 19,970,330 | 20,092,340 |
| RSUs | 3,155,558 | 3,444,892 |
| Ordinary share warrants | 2,016,321 | 2,016,330 |
| Redeemable convertible preferred shares | 5,000,000 | 5,000,000 |
| Net potential dilutive outstanding securities | 33,304,195 | 35,040,350 |
NOTE 15 -SUBSEQUENT EVENTS
Exchangeable Senior Notes
On October 1, 2024, the Company, through a wholly owned subsidiary of the Company, issued $160 million aggregate principal amount of its 6.125% Exchangeable Senior Notes (“Notes”) due 2029. The issuance was in connection with a purchase agreement dated September 26, 2024, with certain initial purchasers. The Notes bear interest at a rate of 6.125% per annum, payable semiannually in arrears on April 1 and October 1 of each year, beginning April 1, 2025. The Notes will mature on October 1, 2029, unless earlier repurchased, redeemed, or exchanged.
The Notes are exchangeable for cash, Class A Ordinary Shares (no par value) of the Company, or a combination of cash and Class A Ordinary Shares, at the election of the Company, subject to certain conditions.
Acquisition of Theorem
On October 22, 2024, the Company completed the acquisition of Theorem Technology, Inc. (“Theorem”), a Silicon Valley-based institutional asset manager focused exclusively on the consumer credit space, managing assets for global institutional investors since its founding in 2014. The Company acquired 100% of Theorem’s equity for approximately $17.5 million, consisting of $10.0 million cash and 504,440 of the Company’s Class A Ordinary Shares ($7.5 million worth as of the closing date), with an additional contingent consideration based on achievement of certain performance objectives defined in the purchase agreement. As the transaction has closed recently, the purchase accounting has not yet been
Credit Agreement Amendment
On November 5, 2024, the Company entered into Amendment No. 2 (the “Amendment”) to the Credit Agreement (see Note 4), dated as of February 2, 2024. Pursuant to the Amendment, the Company incurred incremental term loans in an aggregate principal amount of $72 million (with the ability to incur additional incremental term loans in an aggregate principal amount up to $28 million on or before December 31, 2024), bringing the total principal amount of the Term Loan Facility to $327 million.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.